English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907539      Online Users : 943
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9098


    Title: Anticancer oral formulation
    Authors: Yeh, TK;Chen, CT;Chao, YS
    Contributors: Institute of Biotechnology and Pharmaceutical Research
    Abstract: 本発明は、一部では、Ｎ－（３－メチルイソチアゾール－５－イル）－２－［１－（３－メチルイソキサゾール－５－イルメチル）－１Ｈ－インドール－３－イル］－２－オキソアセトアミドを含む経口製剤が、予想外に、経口によるバイオアベイラビリティを高めるという発見に基づくものである。
    Date: 2014-08-15
    Relation: 特許第5596680號/2014-08-15
    Link to: https://www.j-platpat.inpit.go.jp/web/all/top/BTmTopPage
    Appears in Collections:[葉燈光] 專利
    [陳炯東] 專利
    [趙宇生(2002-2013)] 專利

    Files in This Item:

    There are no files associated with this item.



    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback